GlobalData on MSN7d
RevBio receives $2.4m from NIH to advance bone adhesive trialUS-based bone adhesive company RevBio has received a $2.4 million grant from the National Institutes of Health (NIH) to drive the company’s completion of a 20-patient trial of its bone adhesive ...
Hip replacement involves replacing the joint with a prosthesis housed in the femoral canal Recovery and re-education times ...
Our alliance partnership with J&J MedTech reflects their confidence in our ability to deliver the highest standards of safety ...
She says that the situation is now changing with the development of musculoskeletal ultrasound, during which probes can be applied to the skin to see adhesions ... organs and bone. The good news is ...
Sickle cell disease causes severe pain that’s hard to treat, but researchers are finding new ways to offer relief ...
15d
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...
Patients with sickle cell anemia (SCA) and persistent albuminuria (PA) exhibited significantly higher levels of urinary ...
Given the prevalence of Danon disease across regions, the Company plans to pursue regulatory filings concomitantly in the U.S. and ex-U.S. “From a clinical perspective, the important thing is that we ...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback